Commonwealth Coat of Arms of Australia
 

 

PB 9 of 2025

 

National Health (Originator Brand) Amendment Determination (No. 1) 2025

 I, Rebecca Richardson, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care, make the following Determination.

Dated           30      January 2025  

REBECCA RICHARDSON

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health and Aged Care


1  Name

2  Commencement

3  Authority

4  Schedules

Schedule 1—Amendments

National Health (Originator Brand) Determination 2015 (PB 100 of 2015)

 

 

  This instrument is the National Health (Originator Brand) Amendment Determination (No. 1) 2025.

  This instrument may also be cited as PB 9 of 2025.

 (1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

 1 February 2025

 

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

 (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

  This instrument is made under subsection 99ADB(6B) of the National Health Act 1953.

  Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

1  Schedule 1, (after table item 54)

 

Repeal:

 

55

Cyproterone

Androcur

Androcur100

 

 

55A

Dabigatran etexilate

Pradaxa

 

 

55B

Darunavir

Prezista

 

 

55C

Dasatinib

Sprycel

 

 

55D

Deferasirox

Jadenu

 

 

 

Substitute:

 

55

Cyproterone

Androcur

Androcur100

 

 

55A

Dabigatran etexilate

Pradaxa

 

 

55B

Dapsone

Link Medical Products Pty Ltd

 

 

55C

Darunavir

Prezista

 

 

55D

Dasatinib

Sprycel

 

 

55E

Deferasirox

Jadenu

 

 

 

2  Schedule 1, (after table item 139)

 

Insert:

 

139A

Maraviroc

Celsentri

 

 

 

3  Schedule 1, (after table item 176)

 

Repeal:

 

177

Oxycodone

Endone

OxyNorm

OxyContin

Oral

 

 

 

Proladone

Rectal

 

177A

Palonosetron

Aloxi

 

 

 

 

 

 

 

Substitute:

 

177

Oxycodone

Endone

OxyNorm

OxyContin

Oral

 

 

 

Proladone

Rectal

 

177A

Paclitaxel, nanoparticle albumin-bound

Abraxane

 

 

177B

Palonosetron

Aloxi

 

 

 

4  Schedule 1, (after table item 226)

 

Insert:

 

226A

Ticagrelor

Brilinta